142 related articles for article (PubMed ID: 31562394)
1. High-risk blastemal Wilms tumor can be modeled by 3D spheroid cultures in vitro.
Wegert J; Zauter L; Appenzeller S; Otto C; Bausenwein S; Vokuhl C; Ernestus K; Furtwängler R; Graf N; Gessler M
Oncogene; 2020 Jan; 39(4):849-861. PubMed ID: 31562394
[TBL] [Abstract][Full Text] [Related]
2. The role of TCF3 as potential master regulator in blastemal Wilms tumors.
Kehl T; Schneider L; Kattler K; Stöckel D; Wegert J; Gerstner N; Ludwig N; Distler U; Tenzer S; Gessler M; Walter J; Keller A; Graf N; Meese E; Lenhof HP
Int J Cancer; 2019 Mar; 144(6):1432-1443. PubMed ID: 30155889
[TBL] [Abstract][Full Text] [Related]
3. Multidrug resistance transporter profile reveals MDR3 as a marker for stratification of blastemal Wilms tumour patients.
Hontecillas-Prieto L; Garcia-Dominguez DJ; Vaca DP; Garcia-Mejias R; Marcilla D; Ramirez-Villar GL; Saez C; de Álava E
Oncotarget; 2017 Feb; 8(7):11173-11186. PubMed ID: 28061436
[TBL] [Abstract][Full Text] [Related]
4. SIX1 protein expression selectively identifies blastemal elements in Wilms tumor.
Sehic D; Karlsson J; Sandstedt B; Gisselsson D
Pediatr Blood Cancer; 2012 Jul; 59(1):62-8. PubMed ID: 22180226
[TBL] [Abstract][Full Text] [Related]
5. Glypican 3 overexpression in primary and metastatic Wilms tumors.
Tretiakova M; Zynger DL; Luan C; Andeen NK; Finn LS; Kocherginsky M; Teh BT; Yang XJ
Virchows Arch; 2015 Jan; 466(1):67-76. PubMed ID: 25366870
[TBL] [Abstract][Full Text] [Related]
6. The in vitro growth, heterotransplantation, and immunohistochemical characterization of the blastemal component of Wilms' tumor.
Garvin AJ; Sullivan JL; Bennett DD; Stanley WS; Inabnett T; Sens DA
Am J Pathol; 1987 Nov; 129(2):353-63. PubMed ID: 2445211
[TBL] [Abstract][Full Text] [Related]
7. Identical genetic changes in different histologic components of Wilms' tumors.
Zhuang Z; Merino MJ; Vortmeyer AO; Bryant B; Lash AE; Wang C; Deavers MT; Shelton WF; Kapur S; Chandra RS
J Natl Cancer Inst; 1997 Aug; 89(15):1148-52. PubMed ID: 9262253
[TBL] [Abstract][Full Text] [Related]
8. Characterization of primary Wilms tumor cultures as an in vitro model.
Wegert J; Bausenwein S; Roth S; Graf N; Geissinger E; Gessler M
Genes Chromosomes Cancer; 2012 Jan; 51(1):92-104. PubMed ID: 22034155
[TBL] [Abstract][Full Text] [Related]
9. Expression and prognostic value of epidermal growth factor receptor, transforming growth factor-alpha, and c-erb B-2 in nephroblastoma.
Ghanem MA; Van Der Kwast TH; Den Hollander JC; Sudaryo MK; Mathoera RB; Van den Heuvel MM; Noordzij MA; Nijman RJ; van Steenbrugge GJ
Cancer; 2001 Dec; 92(12):3120-9. PubMed ID: 11753991
[TBL] [Abstract][Full Text] [Related]
10. Blastemal predominant type Wilms tumor in Japan: Japan Children's Cancer Group.
Koshinaga T; Takimoto T; Okita H; Tanaka Y; Inoue E; Oue T; Nozaki M; Tsuchiya K; Haruta M; Kaneko Y; Fukuzawa M
Pediatr Int; 2019 Apr; 61(4):351-357. PubMed ID: 30786111
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of CITED1, SIX1, and CD56 protein expression for identification of blastemal elements in Wilms tumor.
Sehic D; Ciornei CD; Gisselsson D
Am J Clin Pathol; 2014 Jun; 141(6):828-33. PubMed ID: 24838327
[TBL] [Abstract][Full Text] [Related]
12. The epithelial mesenchymal transition process in wilms tumor: a study based on a xenograft model.
Giner F; Machado I; Noguera R; Villamon E; Pellin A; Calabuig-Fariñas S; Peydro-Olaya A; Navarro S; Llombart-Bosch A
Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):369-75. PubMed ID: 21285869
[TBL] [Abstract][Full Text] [Related]
13. Developmental tumourigenesis: NCAM as a putative marker for the malignant renal stem/progenitor cell population.
Pode-Shakked N; Metsuyanim S; Rom-Gross E; Mor Y; Fridman E; Goldstein I; Amariglio N; Rechavi G; Keshet G; Dekel B
J Cell Mol Med; 2009 Aug; 13(8B):1792-1808. PubMed ID: 20187302
[TBL] [Abstract][Full Text] [Related]
14. Gene expression analysis of blastemal component reveals genes associated with relapse mechanism in Wilms tumour.
Maschietto M; Piccoli FS; Costa CM; Camargo LP; Neves JI; Grundy PE; Brentani H; Soares FA; Camargo Bd; Carraro DM
Eur J Cancer; 2011 Dec; 47(18):2715-22. PubMed ID: 21703850
[TBL] [Abstract][Full Text] [Related]
15. The isolation and characterization of renal cancer initiating cells from human Wilms' tumour xenografts unveils new therapeutic targets.
Pode-Shakked N; Shukrun R; Mark-Danieli M; Tsvetkov P; Bahar S; Pri-Chen S; Goldstein RS; Rom-Gross E; Mor Y; Fridman E; Meir K; Simon A; Magister M; Kaminski N; Goldmacher VS; Harari-Steinberg O; Dekel B
EMBO Mol Med; 2013 Jan; 5(1):18-37. PubMed ID: 23239665
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Eribulin Combined with Irinotecan for Treatment of Pediatric Cancer Xenografts.
Robles AJ; Kurmasheva RT; Bandyopadhyay A; Phelps DA; Erickson SW; Lai Z; Kurmashev D; Chen Y; Smith MA; Houghton PJ
Clin Cancer Res; 2020 Jun; 26(12):3012-3023. PubMed ID: 32184294
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive Analysis of a Long Noncoding RNA-Associated Competing Endogenous RNA Network in Wilms Tumor.
Zhang F; Zeng L; Cai Q; Xu Z; Liu R; Zhong H; Mukiibi R; Deng L; Tang X; Xin H
Cancer Control; 2020; 27(2):1073274820936991. PubMed ID: 32597194
[TBL] [Abstract][Full Text] [Related]
18. Immunoexpression of SALL4 in Wilms tumors and developing kidney.
Deisch J; Raisanen J; Rakheja D
Pathol Oncol Res; 2011 Sep; 17(3):639-44. PubMed ID: 21258884
[TBL] [Abstract][Full Text] [Related]
19. RNA expression of the WT1 gene in Wilms' tumors in relation to histology.
Miwa H; Tomlinson GE; Timmons CF; Huff V; Cohn SL; Strong LC; Saunders GF
J Natl Cancer Inst; 1992 Feb; 84(3):181-7. PubMed ID: 1311774
[TBL] [Abstract][Full Text] [Related]
20. Association between the HER2 expression and histological differentiation in Wilms tumor.
Salem M; Kinoshita Y; Tajiri T; Souzaki R; Tatsuta K; Higashi M; Izaki T; Kohashi K; Tsuneyoshi M; Taguchi T
Pediatr Surg Int; 2006 Nov; 22(11):891-6. PubMed ID: 16932912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
